| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.37 | 0.004 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.42 | 0.01 |